Proteomics approaches in cervical cancer: focus on the discovery of biomarkers for diagnosis and drug treatment monitoring.,Expert Review of Proteomics

当前位置： X-MOL 学术 › Expert Rev. Proteomics › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Proteomics approaches in cervical cancer: focus on the discovery of biomarkers for diagnosis and drug treatment monitoring.
Expert Review of Proteomics ( IF 3.4 ) Pub Date : 2016-07-12 , DOI: 10.1080/14789450.2016.1210514
Georgia Kontostathi _{1,

2} , Jerome Zoidakis ₁ , Nicholas P Anagnou _{2,

3} , Kalliopi I Pappa _{3,

4} , Antonia Vlahou ₁ , Manousos Makridakis ₁

Affiliation

INTRODUCTION The HPV virus accounts for the majority of cervical cancer cases. Although a diagnostic tool (Pap Test) is widely available, cervical cancer incidence still remains high worldwide, and especially in developing countries, attributed to a large extent to suboptimal sensitivities of the Pap test and unavailability of the test in developing countries. AREAS COVERED Proteomics approaches have been used in order to understand the HPV virus correlation to cervical cancer pathology, as well as to discover putative biomarkers for early cervical cancer diagnosis and drug mode of action. Expert commentary: The present review summarizes the latest in vitro and in vivo proteomic studies for the discovery of putative cervical cancer biomarkers and the evaluation of available drugs and treatments.

更新日期：2019-11-01

点击分享查看原文

点击收藏

阅读更多本刊最新论文本刊介绍/投稿指南

全部期刊列表>>